Click to view your profile
Click to search for condition or expert
Click to open main menu
Cholangiocarcinoma (Bile Duct Cancer) Latest Advances
Find the Latest Research About Cholangiocarcinoma (Bile Duct Cancer)
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/20/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 322 publications
See more filters
Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma in patients aged 60 and older: a retrospective cohort study.
Condition:
Intrahepatic Cholangiocarcinoma (ICC) in Older Patients
Journal:
World journal of surgical oncology
Treatment Used:
Laparoscopic Hepatectomy (LH)
Number of Patients:
107
Published:
December 12, 2022
VIEW PUBLICATION
A case report of Wernicke Korsakoff syndrome in a patient with cholangiocellular carcinoma: An underestimated cause of encephalopathy in cancer patients.
Condition:
Wernicke Korsakoff Syndrome in Patient with Cholangiocellular Carcinoma
Journal:
Medicine
Treatment Used:
Thiamin
Number of Patients:
1
Published:
December 09, 2022
VIEW PUBLICATION
Optimization of a laparoscopic procedure for advanced intrahepatic cholangiocarcinoma based on the concept of "waiting time": a preliminary report.
Condition:
Advanced Intrahepatic Cholangiocarcinoma (ICC)
Journal:
BMC cancer
Treatment Used:
Three-Step Optimized Laparoscopic Surgery
Number of Patients:
42
Published:
November 28, 2022
VIEW PUBLICATION
Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study.
Condition:
Combined Hepatocellular-Cholangiocarcinoma (cHCC)
Journal:
World journal of gastroenterology
Treatment Used:
Radical Resection and Transarterial Chemoembolization (TACE)
Number of Patients:
95
Published:
November 21, 2022
VIEW PUBLICATION
Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Condition:
T1N0M0 Intrahepatic Cholangiocarcinoma (ICC)
Journal:
BMC cancer
Treatment Used:
Adjuvant Chemotherapy After Radical Resection
Number of Patients:
148
Published:
November 11, 2022
VIEW PUBLICATION
Liver transplantation and intrahepatic cholangiocarcinoma: time to go forward again?
Condition:
Intrahepatic Cholangiocarcinoma (iCCA)
Journal:
Current opinion in organ transplantation
Treatment Used:
Liver Transplantation
Number of Patients:
0
Published:
November 10, 2022
VIEW PUBLICATION
Combined hepatocellular carcinoma-cholangiocarcinoma in a patient with Fontan-associated liver disease.
Condition:
Combined Hepatocellular Carcinoma-Cholangiocarcinoma
Journal:
BMJ case reports
Treatment Used:
Chemotherapy
Number of Patients:
1
Published:
November 07, 2022
VIEW PUBLICATION
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14).
Condition:
HER2-Positive Biliary Tract Cancer
Journal:
The lancet. Gastroenterology & hepatology
Treatment Used:
Trastuzumab Plus FOLFOX
Number of Patients:
34
Published:
November 03, 2022
VIEW PUBLICATION
Disitamab vedotin, a novel HER2-directed antibody-drug conjugate in gastric cancer and other solid tumors.
Condition:
Gastric Cancer and Other Solid Tumors
Journal:
Drugs of today (Barcelona, Spain : 1998)
Treatment Used:
Disitamab Vedotin
Number of Patients:
0
Published:
October 28, 2022
VIEW PUBLICATION
Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress.
Condition:
Intrahepatic Cholangiocarcinoma (CCA)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Pemigatinib
Number of Patients:
0
Published:
October 27, 2022
VIEW PUBLICATION
Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective.
Condition:
Advanced Unresectable Biliary Tract Cancer (BTC)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Systemic Therapies
Number of Patients:
0
Published:
October 27, 2022
VIEW PUBLICATION
Vater Papilla-preserving Strategy for Advanced Hepatocellular Carcinoma With Excessive Bile Duct Tumor Thrombus.
Condition:
Advanced Hepatocellular Carcinoma (HCC) with Excessive Bile Duct Tumor Thrombus (BDTT)
Journal:
Anticancer research
Treatment Used:
Vater Papilla-Preserving Strategy
Number of Patients:
1
Published:
October 26, 2022
VIEW PUBLICATION
Showing 1-12 of 322
Next
Last Updated: 01/20/2023